Dr Lal PathLabs (NSE:LALPATHLAB), India's foremost network of national reference laboratories, clinical laboratories, patient service centers and sample pick up points today announced the use of drones for transporting blood samples. The use of drones would expand Dr Lal Pathlab's services of high-quality and advanced diagnostics to underserved and inaccessible locations. Time is critical in providing accurate reports to the treating physicians and helping them start the optimal treatment. The pilot projects are being launched across multiple remote, semi-urban and rural locations to experiment multiple-use cases that eliminate challenges like congestion due to traffic, poor road conditions and inaccessibility.
Commenting on the use of drones for transporting biological samples, Amit Aggarwal, Head Logistics & Home Collection, said "As the leader in diagnostic industry, Dr Lal PathLabs is committed towards integration of new technologies into its existing logistics systems to further expedite sample collections. The use of drones could significantly speed-up regular and emergency medical care in rural areas and help save lives. We are initiating pilot projects in different parts of the country. If these first trial runs are successful, we are hopeful to expand drone sample collection services at scale across India soon."
Shares of Dr. Lal Path Labs Ltd. was last trading in BSE at Rs. 2781.40 as compared to the previous close of Rs. 2731.90. The total number of shares traded during the day was 23784 in over 3180 trades.
The stock hit an intraday high of Rs. 2850.00 and intraday low of 2733.65. The net turnover during the day was Rs. 66360026.00.